Skip to main content
Filter By
Hearing
Investigating Pandemic Immunity: Acquired, Therapeutic or Both

Press Release
Grothman: U.S. Naval Shipbuilding Capacity Must Compete With China & Russia

WASHINGTON — National Security, the Border, and Foreign Affairs Subcommittee Chairman Glenn Grothman (R-Wis.) opened today’s subcommittee hearing on “Strengthening the Fleet: Challenges and Solutions in Naval Surface Ship Construction ” by outlining how the Navy has struggled to produce a coherent long-term, 30-year shipbuilding strategy that is able ...

Press Release
Comer to Hold Second Oversight Hearing on the District of Columbia

WASHINGTON—House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) will hold a full committee hearing titled “Overdue Oversight of the Capital City: Part II” This hearing will be the second held by Committee to address general oversight of the District of Columbia, including crime, safety, and city management. “Radical left-wing policies pushed in our ...

Press Release
Wenstrup: COVID-19 Naturally Acquired Immunity Could Have Been a Force Multiplier for Good

WASHINGTON — Select Subcommittee on the Coronavirus Pandemic Chairman Brad Wenstrup (R-Ohio) opened today’s hearing on “Investigating Pandemic Immunity: Acquired, Therapeutic or Both” by asking why naturally acquired immunity was never considered in the public health response to the COVID-19 pandemic. Chairman Wenstrup called attention to global research and data that quickly proved those who contracted COVID-19 had antibodies that provided some level of immunity against ...

Press Release
McClain: The FDA Must Act to Improve Internal Controls and Prevent Crises from Happening Again

WASHINGTON—Subcommittee on Health Care and Financial Services Chairwoman Lisa McClain (R-Mich.) opened a subcommittee hearing titled “FDA Oversight Part II: Responsibility for the Infant Formula Shortage” by discussing how today’s hearing is crucial in continuing the subcommittee’s investigation into the Food and Drug Administration’s (FDA) response to the infant formula crisis. Chairwoman McClain emphasized that the FDA must be held accountable for being unprepared to handle ...

Press Release
Hearing Wrap Up: Lack of Commercial Investment, Unclear Goals, and Manufacturing Failures Have Given Maritime Advantage to China Over U.S.

WASHINGTON—The Subcommittee on National Security, the Border, and Foreign Affairs held a hearing titled, “Strengthening the Fleet: Challenges and Solutions in Naval Surface Ship Construction.” Subcommittee members discussed with witnesses how the U.S. Navy can produce more quality, and efficient ships to meet demands of the U.S. national security ...

Press Release
Hearing Wrap Up: FDA’s Food Safety Director Acknowledges ‘Less Than Ideal’ Slow Response to Formula Crisis

WASHINGTON—Today, the Subcommittee on Health Care and Financial Services held a hearing titled “FDA Oversight Part II: Responsibility for the Infant Formula Shortage.” At the hearing, members asked Dr. Susan Mayne, Director of the Center for Food Safety and Applied Nutrition, questions about the Food and Drug Administration’s (FDA) response to ...

Press Release
Wenstrup to Hold Hearing on COVID-19 Nursing Home Policy Failures

WASHINGTON — Select Subcommittee on the Coronavirus Pandemic Chairman Brad Wenstrup (R-Ohio) will hold a hearing titled “’Like Fire Through Dry Grass’: Nursing Home Mortality & COVID-19 Policies” to gather facts about pandemic-era, nursing home policy decisions — specifically in New York, New Jersey, and Pennsylvania — that led to the deaths of tens of thousands of Americans. Instead of protecting the most vulnerable population, Governor Andrew Cuomo (D-N.Y.) and other ...

Hearing
Risky Business: Costly Inaction on Federal Legacy IT

Hearing
ESG Part I: An Examination of Environmental, Social, and Governance Practices with Attorneys General